Adjuvant Ipilimumab vs Placebo After Complete Resection of Stage III Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Adjuvant Ipilimumab Versus Placebo After Complete Resection of Stage III Melanoma: Long-Term Follow-Up Results of the European Organisation for Research and Treatment of Cancer 18071 Double-Blind Phase 3 Randomised Trial
Eur. J. Cancer 2019 Sep 01;119(xx)1-10, AMM Eggermont, V Chiarion-Sileni, JJ Grob, R Dummer, JD Wolchok, H Schmidt, O Hamid, C Robert, PA Ascierto, JM Richards, C Lebbe, V Ferraresi, M Smylie, JS Weber, M Maio, F Hosein, V de Pril, M Kicinski, S Suciu, A TestoriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.